Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,805
Sort by:
Japan Gene Therapy Market - 2024-2033
US$ 2,999.00
The Japan Gene Therapy Market was valued at US$ 148.06 Million in 2024 and is anticipated to reach US$ 904.94 Million by 2033, at a CAGR of 0.203 from 2026 to 2032. The report delivers in-depth insigh...
April 2026
219 pages
US Biosimilars Market - 2024-2033
US$ 2,999.00
The US Biosimilars Market was valued at US$ 8.62 billion in 2024 and is anticipated to reach US$ 65.62 billion by 2033, at a CAGR of 0.255 from 2026 to 2032. The report delivers in-depth insights into...
April 2026
207 pages
Antisense Oligonucleotides Market - 2025-2033
US$ 2,999.00
The Antisense Oligonucleotides Market was valued at US$ 3,180.1 million in 2025 and is anticipated to reach US$ 5,286.96 million by 2033, at a CAGR of 0.065 from 2026 to 2032. The report delivers in-d...
April 2026
223 pages
